Horizon Acquisition Corp II Shares See Volume; Traders Circulate Front Office Sports Tweet Highlighting Trading Cards As NFTs. BZ NOTE: Benzinga Can Not Confirm That Front Office Sports Is Co's Merger Partner
$HZON
Blank Checks
Finance
Save time and jump to the most important pieces.
4 - Horizon Acquisition Corp II (0001821788) (Issuer)
4 - Horizon Acquisition Corp II (0001821788) (Issuer)
3 - Horizon Acquisition Corp II (0001821788) (Issuer)
15-12G - Horizon Acquisition Corp II (0001821788) (Filer)
25-NSE - Horizon Acquisition Corp II (0001821788) (Subject)
10-K - Horizon Acquisition Corp II (0001821788) (Filer)
SC 13G/A - Horizon Acquisition Corp II (0001821788) (Subject)
SC 13G/A - Horizon Acquisition Corp II (0001821788) (Subject)
SC 13G - Horizon Acquisition Corp II (0001821788) (Subject)
Flexjet's Strong Financial Performance Will Allow for Continued Opportunistic Acquisitions, As Well As Strategic Growth in Infrastructure, Fleet, and Geographic Expansion Without the Need for Public Capital. Flexjet, Inc., a global leader in subscription-based private aviation today announced that it has agreed to terminate its previously announced business combination agreement with Horizon Acquisition Corporation II ("Horizon") (NYSE:HZON), a publicly traded special purpose acquisition company, that would have resulted in Flexjet becoming a publicly listed company. As a result of the termination, Flexjet will remain a private company. "Because we have been dedicated stewards of our
– Flexjet and Horizon entered into a business combination agreement in October 2022 – The parties have terminated the business combination agreement – Flexjet has agreed to make a termination payment to Horizon that will enable Horizon to make a liquidating distribution to the holders of its Class A ordinary shares expected to be approximately $11.33 per share Horizon Acquisition Corporation II (NYSE:HZON), a publicly traded special purpose acquisition company, announced today that it has agreed to terminate its business combination agreement with Flexjet, Inc. As a result of the termination, Flexjet will remain a private company, and Horizon will liquidate its trust account and redee
Cleveland, OH, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Chief Executive Officer of Flexjet , a global leader in subscription-based private aviation, has received the Living Legends of Aviation Lifetime Aviation Industry Award. Michael J. "Mike" Silvestro, who is the longest tenured CEO in the fractional aviation industry, was given the group's highest honor at its 20th annual awards event on Jan. 20, 2023, hosted by John Travolta at the Beverly Hilton Hotel in Beverly Hills, California. "I am thrilled that the Living Legends of Aviation has honored Mike Silvestro with its Lifetime Aviation Industry Award," said Flexjet Chairman Kenn Ricci, himself a recipient of the Lifetime Aviation En
Gainers TESSCO Technologies Incorporated (NASDAQ:TESS) shares jumped 86.8% to $8.78 as it agreed to be acquired by entities affiliated with Lee Equity Partners and Twin Point Capital for $9.00 in cash, resulting in an enterprise value of $161.4 million. National CineMedia, Inc. (NASDAQ:NCMI) jumped 84% to $0.37. National CineMedia disclosed filing a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas. Altamira Therapeutics Ltd. (NASDAQ:CYTO) gained 64.8% to $2.1759 after the company reported publication of results from Phase 2 trial with AM-125 in acute vestibular syndrome in leading peer reviewed journal. HeartCore Enterprises, Inc. (NASDAQ:H
Gainers HeartCore Enterprises, Inc. (NASDAQ:HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win. Altamira Therapeutics Ltd. (NASDAQ:CYTO) gained 81.8% to $2.40 in pre-market trading after dropping 36% on Tuesday. Liquid Media Group Ltd. (NASDAQ:YVR) climbed 54.4% to $0.23 in pre-market trading after dropping 17% on Tuesday. Liquid Media Group recently announced it received an additional deficiency notice from Nasdaq. Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 48.8% to $0.6444 in pre-market trading after gaining 5% on Tuesday. Panbela regained worldwide rights to develop and commercialize